White Crystal Citicoline Sodium API Intermediate CAS 33818-15-4

Product Description

Product Information of API Powder

Cytophosphatidylcholine is a nucleic acid derivative. In 1956, Geiger discovered in animal tests that cytophosphatidylcholine could recover from brain damage; in 1957, Kennedy's research confirmed its importance in the synthesis of brain phospholipids, and in 1961, Takeda Pharmaceutical Company of Japan developed and produced this product, which was registered in China in 1988. It is currently the best-selling drug used clinically in the treatment of brain diseases and plays an important role in the synthesis of lecithin, improving brain function by promoting the synthesis of lecithin. It has been proved that cytarabine enhances norepinephrine and dopamine levels in the central nervous system, thus treating cognitive impairment caused by cerebrovascular disease, traumatic brain injury and various causes of Chemicalbook, and has no significant side effects.

Certificate of Analysis

Pharmacological Effects of API Powder

Citicoline Sodium enhances the function of the brainstem reticular formation, especially the activating system of the superior reticular formation, which is closely related to consciousness, enhances the action of the pyramidal system, inhibits the action of the extrapyramidal system and promotes arousal. It also reduces cerebral vascular resistance, increases cerebral blood perfusion and promotes brain substance metabolism. It is mainly used for the treatment of neurological sequelae caused by craniocerebral injury and cerebrovascular accidents, and can be used for the treatment of Parkinson's syndrome and has a certain effect on senile dementia; it is used for the treatment of cerebrovascular and cardiovascular diseases; other therapeutic effects such as delaying aging, improving learning effect and memory are also certain.

Cytidine 5'-bis-choline phosphate (CDP-choline), which supports the synthesis of lecithin, is produced in choline-phosphate cytidylyltransferase EC 2.7.7.15; used to study its role in neurorehabilitation.